Press releases
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
- Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
- Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
- Edwards Lifesciences Reports Fourth Quarter Results
More ▼
Key statistics
As of last trade EDWARDS LIFEDRN (E1WL34:SAO) traded at 108.24, -9.89% below its 52-week high of 120.12, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 108.35 |
---|---|
High | 108.35 |
Low | 108.24 |
Bid | 107.53 |
Offer | 107.91 |
Previous close | 108.24 |
Average volume | 10.86 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 06 2024 17:57 BST.
More ▼